National · 2 sources
Glenmark Pharmaceuticals Q2 Profit Plunges 56.7% To ₹264 Crore
Coverage by lean
0% Left50% Centre50% Lean Right
Left 0
No coverage found on this side
Centre 1
Glenmark Pharmaceuticals Q2 Profit Plunges 56.7% To ₹264 CroreFree Press Journal
Right 1
One headline per side, the first Trikon holds. Every outlet is listed below.
Left · 0
No coverage found on this side.
Centre · 1
Free Press Journal · Centre
Glenmark Pharmaceuticals Q2 Profit Plunges 56.7% To ₹264 Crore
◈ Indian National Press (Bombay), Karnani family
Right · 1
Business Standard · Lean Right
Glenmark Pharma Q2 revenue falls 30% to ₹4,247 crore, profit down 57%
◈ Business Standard Pvt Ltd (Kotak family, Uday Kotak)
Verify with IFCN fact-checkers →BOOMIFCN ↗FactlyIFCN ↗Quint WebQoofIFCN ↗Vishvas NewsIFCN ↗Google Fact Check ↗